The Exemplary Career of Oncologist Mikhail Blagosklonny
According to Impact Journals, Mikhail Blagosklonny is a famously known scientist in the field of Cancer and aging. Besides, he is a professor of Oncology at the Roswell Park Cancer Institute in New York. Getting Stronger revealed that as a young boy, Mikhail Blagosklonny had an intense love for humanity and a vision of having a disease-free community, a factor that drove him into his career path.
He earned his MD in Internal Medicine from the Medical University of St. Petersburg, and later got a Ph.D. in Experimental Medicine and Cardiology from the same university.
In 2002, he was made the associate professor of medicine at the New York Medical College. Before joining the Roswell Park Cancer Institute in 2009, the distinguished professor served as a senior scientist at Ordway Research Institute.
His Career at Roswell Park Cancer Institute
While at Roswell College, the professor has devoted most of his time in studying cancer including therapies to protect normal and healthy cells from getting damaged. Besides, he has interests in understanding the underlying mechanism of aging and anti- aging drugs. His vast experience and excellent achievements have made him become one of the most reputed and outstanding Oncology researchers.
His Editorial Activities
Mikhail Blagosklonny is an author of more than 300 research articles, book chapters and reviews. His research ranges from clinical investigations to cellular and molecular biology. He is also the founding editor and editor-in- chief of the cell cycle.
Moreover, he is an Associate Editor of cancer biology and therapy, PLOS ONE, American Journal of Pathology, Cell death, cancer research, International Journal of Cancer and Autophagy.
In these articles, he has written about ontogenesis, tumor suppressors, apoptosis, anticancer therapeutics, mitosis, drug resistance for healthy cells, and signal transduction among many others.
About TOR Hypothesis
Mikhail Blagosklonny developed a hypothesis regarding TOR (Target of Rapamycin) signaling potential role in Cancer and aging. He proposed the use of Rapamycin, which is a popular cancer drug to be a possible treatment for life extension.
He firmly believes that cancer can be controlled through the control of aging activities of the cell and that’s why he strongly advocated for the use of Rapamycin. The professor is considered to be the most enthusiastic advocate for Rapamycin in longevity research.